Evidence map›Paper›PMID 39129569›Full record

ReviewLa Tunisie medicale2024

Jean Claude Majambere, Sanae Zaidi, Abderrahmane Errami, Latifa Marih, Kamal Marhoum El Filali, Ahmed Aziz Bousfiha, Ahd Oulad Lahsen

Abstract readReviewEnglish Abstract
In one paragraph

Review in La Tunisie medicale, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jean Claude MajambereClinical Immunology, Inflammation and Allergy Laboratory, Faculty of Medicine and Pharmacy, Casablanca, Hassan II University of Casablanca.
Sanae ZaidiClinical Immunology, Inflammation and Allergy Laboratory, Faculty of Medicine and Pharmacy, Casablanca, Hassan II University of Casablanca.
Abderrahmane ErramiClinical Immunology, Inflammation and Allergy Laboratory, Faculty of Medicine and Pharmacy, Casablanca, Hassan II University of Casablanca.
Latifa MarihInfectious Diseases Department, Ibn Rochd University Hospital, Casablanca.
Kamal Marhoum El FilaliInfectious Diseases Department, Ibn Rochd University Hospital, Casablanca.
Ahmed Aziz BousfihaClinical Immunology, Inflammation and Allergy Laboratory, Faculty of Medicine and Pharmacy, Casablanca, Hassan II University of Casablanca.
Ahd Oulad LahsenClinical Immunology, Inflammation and Allergy Laboratory, Faculty of Medicine and Pharmacy, Casablanca, Hassan II University of Casablanca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculous meningitis, a severe form of tuberculosis caused by Mycobacterium tuberculosis (BK), remains a major public health challenge worldwide. In addition to the complex mechanisms of the innate and adaptive immune response against Mycobacterium tuberculosis, there is a crucial genetic dimension to consider. Individuals with specific genetic variations may have altered immune responses that make them more susceptible to this form of tuberculosis. Genetic mutations in genes encoding surface receptors, adaptor proteins, kinases, transcription factors, nucleic receptors and other molecules involved in cellular interactions and molecular mechanisms have been associated with susceptibility to TB. Understanding the molecular mechanisms of immune interactions in host response to Mycobacterium tuberculosis is crucial to understanding the genetic dimension in susceptibility to tuberculosis, particularly its dreaded form of tuberculous meningitis. The aim of this update is to explore in details the key interactions between the main players in innate and adaptive immunity during infection with Mycobacterium tuberculosis, with particular emphasis on the genetic factors associated with susceptibility to tuberculosis, especially its dreaded form of tuberculous meningitis.

Indexed as

Genetic Predisposition to DiseaseMycobacterium tuberculosisTuberculosis, MeningealAdaptive ImmunityHumansImmunity, InnateCytokinesGenetic predispositionImmune responseMycobacterium tuberculosisSurface receptorsTranscription factorsTuberculous meningitis

Identifiers

PMID39129569
PMCPMC11387960

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.